Trials / Completed
CompletedNCT00062400
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, With Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 385 (estimated)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- Female
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment. PURPOSE: This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
Detailed description
OBJECTIVES: * Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer. * Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation. OUTLINE: This is a multicenter study. Patients complete a questionnaire administered by a nontreating physician. PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.
Conditions
- Breast Cancer
- Psychosocial Effects of Cancer and Its Treatment
- Sexual Dysfunction and Infertility
- Sexuality and Reproductive Issues
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | psychosocial assessment and care |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2008-06-01
- First posted
- 2003-06-06
- Last updated
- 2013-10-24
Locations
27 sites across 15 countries: Belgium, Chile, Croatia, Germany, Italy, Lebanon, Netherlands, Peru, Poland, Portugal, Serbia, South Africa, Switzerland, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT00062400. Inclusion in this directory is not an endorsement.